Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

AstraZeneca and SCRI join to develop targeted anticancer agent

Jan. 13, 2011

Seattle Genetics and Pfizer join to develop anticancer antibody-drug conjugates

Jan. 12, 2011

Bristol-Myers Squibb and Pharmasset to evaluate combination treatment for chronic hepatitis C

Jan. 12, 2011

Immutep and GSK enter into agreement for ImmuTune IMP-731

Jan. 12, 2011

Amgen grants MedImmune rights to develop AMG-108 worldwide outside Japan

Jan. 11, 2011

Ziopharm Oncology and Intrexon partner to develop DNA-based oncology therapeutics

Jan. 10, 2011

Spectrum Pharma and Viropro sign agreement for development of rituximab biosimilar

Jan. 10, 2011

Amgen and Xencor to jointly develop XmAb-5871

Jan. 10, 2011

Cynapsus and IntelGenx sign definitive license agreement for INT-0010

Jan. 7, 2011

Omeros licenses new antifibrinolytic agents from University of California

Jan. 7, 2011

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...